Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Summary

This is an open-label, single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of undergoing surgical resection.

Timeline

Start

2023-03-15

Primary completion

2027-02-01

Completion

2028-02-01

Drugs

Indications